Basilea Pharma awarded USD 7.3 million additional CARB-X funding to develop new drug candidate from a novel class of antibiotics: Allschwil, Switzerland Thursday, December 26, 202 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback